Dr. Lin Wang, PhD

Director, Analytical CMC at Gilead Sciences

Speaker

Dr. Lin Wang is Director of Analytical Development at Gilead Sciences, bringing 19 years of research and leadership experience across the pharmaceutical industry, including roles at Eli Lilly, Merck, and Gilead. She leads analytical strategy for small molecule and peptide drug substance and product development, supporting programs from discovery through commercialization across diverse dosage forms. Dr. Wang also sponsors operational excellence initiatives to enhance business processes and organizational efficiency. Her scientific contributions span numerous therapeutic programs, and she has authored over 40 peer-reviewed publications. She earned her PhD in Analytical Chemistry from the University of Florida, receiving the ACS Analytical Chemistry Graduate Fellowship.